M06.02
Rheumatoid arthritis without rheumatoid factor, elbow
Clinical Classification Guidelines
Medical Intelligence & Overview
Rheumatoid arthritis without rheumatoid factor, localized in the elbow, is a form of autoimmune joint disease that specifically impacts the elbow joint without the presence of rheumatoid factor in the blood. This condition involves inflammation of the synovial membrane, leading to pain, swelling, and potential joint damage. Unlike typical rheumatoid arthritis, which often involves multiple joints and is associated with rheumatoid factor antibodies, this form is confined to the elbow and lacks these antibodies, making diagnosis and management distinct.
Causes & Symptoms
Clinical Causes: Autoimmune response where the immune system mistakenly attacks joint tissues Genetic predisposition increases susceptibility Environmental factors, such as smoking and exposure to certain infections or toxins Hormonal influences, which may affect immune function Possible unknown environmental triggers that initiate the autoimmune process
Key Symptoms: Persistent pain in the elbow, especially during movement or activity Swelling and warmth around the affected joint Reduced range of motion and stiffness, particularly in the morning or after periods of inactivity Tenderness upon touch around the elbow Weakness or discomfort during daily activities involving elbow movement Possible crepitus, or a grating feeling, when moving the joint
Diagnostic & Treatment
Diagnosis Path: Physical examination to assess swelling, warmth, and joint mobility Blood tests to rule out other types of arthritis and to check for inflammatory markers such as ESR or CRP, since rheumatoid factor is absent Imaging studies, including X-rays, MRI, or ultrasound, to evaluate joint damage and inflammation Synovial fluid analysis from the elbow joint to detect inflammatory changes or exclude infections Review of medical history and symptom progression to differentiate from other joint conditions
Treatment Protocols: Nonsteroidal anti-inflammatory drugs (NSAIDs) for pain and inflammation relief Disease-modifying antirheumatic drugs (DMARDs) such as methotrexate, to slow disease progression Corticosteroids, either orally or via injections, for short-term control of inflammation Physical therapy to maintain joint function and strength Splinting or bracing to support the elbow and reduce strain In some cases, surgical intervention may be necessary to repair or replace severely damaged joints
Clinical Advice & FAQs
Billing Guidance
Is M06.02 a billable ICD-10 code?
Yes, M06.02 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M06.02?
Clinical documentation must specify the nature of Rheumatoid arthritis without rheumatoid factor, elbow and any associated comorbidities for accurate reporting.
Cite this Clinical Reference